The Polycystic Ovary Syndrome Status – A Risk Factor for Future Cardiovascular Disease
نویسندگان
چکیده
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age with a prevalence estimated at 4–8% (Azziz et al., 2004; Moran & Teede, 2009). It is associated with a range of reproductive, obstetric, metabolic and psychological features. Reproductive and obstetric manifestations include hyperandrogenism, menstrual dysfunction, infertility and pregnancy complications, such as early pregnancy loss, gestational diabetes, pregnancy-induced hypertensive disorders and neonatal complications (Boomsma et al., 2006). Additionally, women with PCOS cluster risk factors for cardiovascular disease (CVD) and type 2 diabetes mellitus (DM) as well as the metabolic syndrome (MS). As a consequence, metabolic complications and potential major long-term sequelaes include: an elevated risk of impaired glucose tolerance (IGT), type 2 DM (Legro, 1999, as cited in Moran & Teede, 2009), as well as an increased rate of hypertension and CVD (Shaw et al., 2008). Although there are still aspects to be cleared regarding the longterm consequences of these well-known cardiovascular (CV) risk factors, the research that has been conducted so far seems to indicate that patients with PCOS are at increased risk for adverse CV morbidity and mortality. Of utmost importance is the fact that these women are likely to develop CV disease early, and that even very young and nonobese patients may be affected (Moran & Teede, 2009; Lorenz & Wild, 2007).
منابع مشابه
Endothelial Progenitor Cell Dysfunction in Polycystic Ovary Syndrome: Implications for The Genesis of Cardiovascular Diseases
متن کامل
بررسی عوامل خطرزای بیماریهای قلبی و عروقی بر حسب فنوتیپهای سندرم تخمدان پلیکیستیک در دختران 18-14 ساله دبیرستانی شهر شیراز 1389
Introduction: In patients with polycystic ovary syndrome hyperinsulinaemia, insulin resistance, dyslipidemia and hyperglycemia may represent an increased risk for coronary cardiovascular disease .This study aimed to investigate risk factors for cardiovascular disease based on polycystic ovary syndrome phenotypes in Shiraz. Methods: This Cross-sectional study was performed on 3200 students aged...
متن کاملPnm-5: Midwifery Intensive Cares in Polycystic Ovary Syndrome
Background: Polycystic ovary syndrome is a common endocrine disorder with 3-7% prevalence in the general population and 10% in women of childbearing. This rate has increased in infertile women. The main composition of this syndrome includes anovulation or olygoovulation, clinical and laboratory signs of increased androgens and observation polycystic ovaries on ultrasound in evaluation. In this ...
متن کاملP-205: Effects of Aerobic Exercise on Plasma Lipoproteins in Overweight and Obese Women with Polycystic Ovary Syndrome
Background: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders. Obesity and anovulation in the women affected by this syndrome leads to a type of obesity that is followed by cardiovascular disease, hypertention and cholesterol and lipoprotein improper profiles. Changing the life style, e.g. increasing physical activities is the first approach in controlling PCOS Ma...
متن کاملThe comparison of dietary intake of macronutrients in polycystic ovary syndrome with and without metabolic syndrome
Background: Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in reproductive age women. The prevalence of PCOS among Iranian women is 14.6% based on the Rotterdam definition. PCOS can increase the risk of chronic metabolic complications. Metabolic syndrome (MetS) is one of the most important of them. Insulin resistance is fundamental in PCOS and MetS pathophysiology. MetS ...
متن کامل